BASi has announced the opening of its new European laboratory and office in Warwickshire, UK. The relocation to a new, upgraded facility with expanded labs provides clients with enhanced capabilities throughout Europe.

Like its North American counterparts, the new 10,000 square foot facility offers a comprehensive bioanalytical capability, as well as providing access to the BASi Group’s full range of preclinical and pharmaceutical analysis services for pharmaceutical and biotechnology companies. BASi Europe also distributes the complete line of BASi instruments and equipment, as well as providing support for customers and distributors throughout Europe.

“BASi Europe offers over a thousand established and validated analytical methods and procedures,” said Mark Wareing, managing director of BASi Europe. “We currently have multiple industry standard LC-MS/MS stations as well as LC-EC and other analytical technologies, and we are investing in two more high-sensitivity MS/MS instruments with state-of-the-art front-end analytical systems. We offer complete peace of mind with an enviable track record of delivering internationally compliant GLP/GCP regulated studies.”

Visit with Mark Wareing, BASi Europe managing director, and other BASi representatives at the upcoming AAPS Annual Meeting and Exhibition, November 16-20, Atlanta, GA. Stop by booth #1016.

About BASi

BASi provides contract research services and specialized instrumentation and accessories for electrochemistry and in vivo sampling products to the world’s leading drug development companies. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking new drugs to market. Visit www.BASInc.com for more information about BASi.